Interstitial Lung Diseases in the Veterans Administration Health System - A Retrospective Description of Patient Characteristics, Management, and Outcomes
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 3,000
- Locations
- 1
- Primary Endpoint
- Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Population
Study Overview
Brief Summary
The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Interstitial Lung Disease (ILD) ICD-9 code diagnosis 515.0 or 516.3
Exclusion Criteria
- •Inadequate documentation of patient receiving care for ILD in the health records
Outcomes
Primary Outcomes
Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Population
Time Frame: up to 5 years
Prevalence of Idiopathic Pulmonary Fibrosis in the VISN6 Veterans Administration Patient Population
Time Frame: up to 5 years
Secondary Outcomes
- Accuracy of ICD-9 Codes for diagnosis of Interstitial Lung Disease(up to 5 years)
- Prevalence of Co-morbid Diabetes Mellitus with Interstitial Lung Disease(up to five years)
- Frequency of ICD-9 code diagnosis of Interstitial Lung Disease and clinic consultation with a pulmonary provider(up to 5 years)
Investigators
Robert Tighe
Staff Physician
Durham VA Medical Center
